Long-term retention rate of pramipexole in the treatment of Parkinson’s disease

被引：0
作者：
Tapani Keränen
Mervi Tuhkasaari
Hanna Kuusisto
机构：
[1] Tampere University Hospital,Division of Neurology and Rehabilitation
[2] University of Kuopio,Department of Pharmacology and Toxicology
来源：
European Journal of Clinical Pharmacology | 2009年 / 65卷
关键词：
Outcome; Parkinson’s disease; Pramipexole; Retention rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：955 / 956
页数：1
相关论文
共 18 条
  • [1] Arbouw MEL(2008)Discontinuation of ropinirole and pramipexole in patients with Parkinson’s disease: clinical practice versus clinical trials Eur J Clin Pharmacol 64 1021-1026
  • [2] Movig KLL(1958)Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457-481
  • [3] Guchelaar H-J(1972)Regression models and life tables J Roy Stat Soc 34 187-220
  • [4] Poels PJE(2001)The long-term safety and efficacy of pramipexole in advanced Parkinson’s disease Parkinsonism Relat Disord 7 115-120
  • [5] van Vugt JPP(2005)Long-term efficacy and safety of pramipexole in advanced Parkinson’s disease: results from a European multicenter trial Mov Disord 20 602-610
  • [6] Neef C(undefined)undefined undefined undefined undefined-undefined
  • [7] Egberts TC(undefined)undefined undefined undefined undefined-undefined
  • [8] Kaplan EL(undefined)undefined undefined undefined undefined-undefined
  • [9] Meier P(undefined)undefined undefined undefined undefined-undefined
  • [10] Cox DR(undefined)undefined undefined undefined undefined-undefined
12